Form 8-K - Current report:
SEC Accession No. 0001558370-24-014749
Filing Date
2024-11-07
Accepted
2024-11-07 07:15:15
Documents
15
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K viri-20241107x8k.htm   iXBRL 8-K 42470
2 EX-99.1 viri-20241107xex99d1.htm EX-99.1 130795
3 GRAPHIC viri-20241107xex99d1002.jpg GRAPHIC 4807
  Complete submission text file 0001558370-24-014749.txt   311630

Data Files

Seq Description Document Type Size
4 EX-101.SCH viri-20241107.xsd EX-101.SCH 3244
5 EX-101.LAB viri-20241107_lab.xml EX-101.LAB 15927
6 EX-101.PRE viri-20241107_pre.xml EX-101.PRE 10042
17 EXTRACTED XBRL INSTANCE DOCUMENT viri-20241107x8k_htm.xml XML 4852
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 241433147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)